Rice Hall James & Associates LLC grew its stake in shares of Ingevity Corp (NYSE:NGVT) by 23.4% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 443,291 shares of the company’s stock after acquiring an additional 83,987 shares during the period. Ingevity accounts for 1.5% of Rice Hall James & Associates LLC’s investment portfolio, making the stock its 11th biggest holding. Rice Hall James & Associates LLC owned 1.06% of Ingevity worth $46,621,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. Victory Capital Management Inc. boosted its holdings in Ingevity by 112.5% in the first quarter. Victory Capital Management Inc. now owns 594,789 shares of the company’s stock worth $62,816,000 after purchasing an additional 314,939 shares in the last quarter. Columbus Circle Investors acquired a new position in shares of Ingevity during the first quarter valued at about $14,251,000. American International Group Inc. raised its position in shares of Ingevity by 232.7% during the first quarter. American International Group Inc. now owns 109,327 shares of the company’s stock valued at $11,546,000 after buying an additional 76,467 shares during the last quarter. Copper Rock Capital Partners LLC raised its position in shares of Ingevity by 29.9% during the second quarter. Copper Rock Capital Partners LLC now owns 298,968 shares of the company’s stock valued at $31,442,000 after buying an additional 68,896 shares during the last quarter. Finally, Redwood Investments LLC raised its position in shares of Ingevity by 64.9% during the first quarter. Redwood Investments LLC now owns 173,606 shares of the company’s stock valued at $18,335,000 after buying an additional 68,300 shares during the last quarter. Institutional investors and hedge funds own 90.33% of the company’s stock.

NYSE NGVT traded down $1.89 during trading hours on Wednesday, hitting $77.61. The company’s stock had a trading volume of 56,157 shares, compared to its average volume of 320,746. The stock has a fifty day moving average of $97.98. Ingevity Corp has a twelve month low of $74.98 and a twelve month high of $120.41. The firm has a market cap of $3.47 billion, a price-to-earnings ratio of 18.79, a P/E/G ratio of 1.68 and a beta of 1.96. The company has a quick ratio of 1.25, a current ratio of 2.28 and a debt-to-equity ratio of 3.51.

Ingevity (NYSE:NGVT) last posted its earnings results on Wednesday, July 24th. The company reported $1.36 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.35 by $0.01. The company had revenue of $352.80 million for the quarter, compared to analyst estimates of $362.06 million. Ingevity had a net margin of 14.03% and a return on equity of 54.67%. The business’s revenue for the quarter was up 14.3% compared to the same quarter last year. During the same period last year, the business posted $1.12 earnings per share. As a group, sell-side analysts anticipate that Ingevity Corp will post 4.92 EPS for the current year.

A number of brokerages have recently commented on NGVT. Berenberg Bank raised shares of Ingevity from a “hold” rating to a “buy” rating and cut their price objective for the company from $120.00 to $110.00 in a research report on Tuesday, May 28th. Jefferies Financial Group lowered shares of Ingevity from a “buy” rating to a “hold” rating and cut their price objective for the company from $129.00 to $107.00 in a research report on Friday, July 19th. BMO Capital Markets began coverage on shares of Ingevity in a research report on Thursday, July 18th. They set an “outperform” rating and a $101.29 price objective for the company. Zacks Investment Research raised shares of Ingevity from a “sell” rating to a “hold” rating in a research report on Thursday, May 9th. Finally, ValuEngine lowered shares of Ingevity from a “hold” rating to a “sell” rating in a research report on Tuesday, August 6th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $108.61.

Ingevity Company Profile

Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats.

Featured Article: Investing in Growth Stocks

Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corp (NYSE:NGVT).

Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.